palmidrol has been researched along with MS (Multiple Sclerosis) in 6 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Central neuropathic pain is a common debilitating symptom in patients with multiple sclerosis." | 1.38 | Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. ( Hesselink, JM; Kopsky, DJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Petrosino, S | 2 |
| Schiano Moriello, A | 1 |
| Migliore, M | 1 |
| Pontis, S | 1 |
| Fuentes de Arriba, AL | 1 |
| Realini, N | 1 |
| Torrente, E | 1 |
| Armirotti, A | 1 |
| Romeo, E | 1 |
| Di Martino, S | 1 |
| Russo, D | 1 |
| Pizzirani, D | 1 |
| Summa, M | 1 |
| Lanfranco, M | 1 |
| Ottonello, G | 1 |
| Busquet, P | 1 |
| Jung, KM | 1 |
| Garcia-Guzman, M | 1 |
| Heim, R | 1 |
| Scarpelli, R | 1 |
| Piomelli, D | 1 |
| Loría, F | 1 |
| Mestre, L | 1 |
| Spagnolo, A | 1 |
| Correa, F | 1 |
| Hernangómez, M | 1 |
| Guaza, C | 1 |
| Di Marzo, V | 1 |
| Docagne, F | 1 |
| Jean-Gilles, L | 1 |
| Feng, S | 1 |
| Tench, CR | 1 |
| Chapman, V | 1 |
| Kendall, DA | 1 |
| Barrett, DA | 1 |
| Constantinescu, CS | 1 |
| Kopsky, DJ | 1 |
| Hesselink, JM | 1 |
| Baker, D | 1 |
| Pryce, G | 1 |
| Croxford, JL | 1 |
| Brown, P | 1 |
| Pertwee, RG | 1 |
| Makriyannis, A | 1 |
| Khanolkar, A | 1 |
| Layward, L | 1 |
| Fezza, F | 1 |
| Bisogno, T | 1 |
| Di Marzo , V | 1 |
1 review available for palmidrol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocan | 2020 |
5 other studies available for palmidrol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Disease Models, Animal; Dose-Response Relati | 2016 |
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Topics: Amides; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cannabinoid Receptor Modulators; Cytoki | 2008 |
Plasma endocannabinoid levels in multiple sclerosis.
Topics: Adult; Aged; Amides; Amidohydrolases; Arachidonic Acids; Brain; Brain Chemistry; Cannabinoid Recepto | 2009 |
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.
Topics: Acupuncture Therapy; Amides; Analgesia; Analgesics; Chronic Disease; Endocannabinoids; Ethanolamines | 2012 |
Endocannabinoids control spasticity in a multiple sclerosis model.
Topics: Amides; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Disease Mo | 2001 |